Identifying Prognostic and Predictive Gene Alterations in Metastatic Prostate Cancer

被引:0
|
作者
Tafe, L. [1 ]
Goyette, E. [1 ]
Pettus, J. [1 ]
Devitskiy, S. [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2020年 / 22卷 / 11期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
ST35
引用
收藏
页码:S69 / S69
页数:1
相关论文
共 50 条
  • [1] An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
    Saxby, Helen
    Mikropoulos, Christos
    Boussios, Stergios
    [J]. DIAGNOSTICS, 2020, 10 (08)
  • [2] Prognostic Values of Gene Copy Number Alterations in Prostate Cancer
    Alfahed, Abdulaziz
    Ebili, Henry Okuchukwu
    Almoammar, Nasser Eissa
    Alasiri, Glowi
    AlKhamees, Osama A.
    Aldali, Jehad A.
    Al Othaim, Ayoub
    Hakami, Zaki H.
    Abdulwahed, Abdulhadi M.
    Waggiallah, Hisham Ali
    [J]. GENES, 2023, 14 (05)
  • [3] Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
    Mo, Fan
    Lin, Dong
    Takhar, Mandeep
    Ramnarine, Varune Rohan
    Dong, Xin
    Bell, Robert H.
    Volik, Stanislav V.
    Wang, Kendric
    Xue, Hui
    Wang, Yuwei
    Haegert, Anne
    Anderson, Shawn
    Brahmbhatt, Sonal
    Erho, Nicholas
    Wang, Xinya
    Gout, Peter W.
    Morris, James
    Karnes, R. Jeffrey
    Den, Robert B.
    Klein, Eric A.
    Schaeffer, Edward M.
    Ross, Ashley
    Ren, Shancheng
    Sahinalp, S. Cenk
    Li, Yingrui
    Xu, Xun
    Wang, Jun
    Wang, Jian
    Gleave, Martin E.
    Davicioni, Elai
    Sun, Yinghao
    Wang, Yuzhuo
    Collin, Colin C.
    [J]. EUROPEAN UROLOGY, 2018, 73 (04) : 524 - 532
  • [4] Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
    I Zlobec
    F Molinari
    M Kovac
    M P Bihl
    H J Altermatt
    J Diebold
    H Frick
    M Germer
    M Horcic
    M Montani
    G Singer
    H Yurtsever
    A Zettl
    L Terracciano
    L Mazzucchelli
    P Saletti
    M Frattini
    K Heinimann
    A Lugli
    [J]. British Journal of Cancer, 2010, 102 : 151 - 161
  • [5] Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients
    Zlobec, I.
    Molinari, F.
    Kovac, M.
    Bihl, M. P.
    Altermatt, H. J.
    Diebold, J.
    Frick, H.
    Germer, M.
    Horcic, M.
    Montani, M.
    Singer, G.
    Yurtsever, H.
    Zettl, A.
    Terracciano, L.
    Mazzucchelli, L.
    Saletti, P.
    Frattini, M.
    Heinimann, K.
    Lugli, A.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (01) : 151 - 161
  • [6] Re: Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer
    Dong, Liang
    Pienta, Kenneth J.
    [J]. EUROPEAN UROLOGY, 2018, 73 (03) : 478 - 478
  • [7] Identifying a predictive biomarker for chemotherapy (taxane) in patients with metastatic castration resistance prostate cancer
    Rothchild, Greg A.
    Sandusky, George
    Temm, Constance J.
    Albany, Costantine
    [J]. CANCER RESEARCH, 2016, 76
  • [8] Discussing the predictive, prognostic, and therapeutic value of germline DNA-repair gene mutations in metastatic prostate cancer patients
    Hauke, Ralph J., Jr.
    Sissung, Tristan M.
    Figg, William D.
    [J]. CANCER BIOLOGY & THERAPY, 2017, 18 (08) : 545 - 546
  • [9] Prognostic and predictive factors in prostate cancer
    Hamdy, FC
    [J]. CANCER TREATMENT REVIEWS, 2001, 27 (03) : 143 - 151
  • [10] Prognostic factors in metastatic prostate cancer
    Yigitbasi, Orhan
    Ozturk, Ufuk
    Goktug, H. N. Goksel
    Gucuk, Adnan
    Bakirtas, Hasan
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (02) : 162 - 165